P
Pashtun Shahim
Researcher at University of Gothenburg
Publications - 46
Citations - 2055
Pashtun Shahim is an academic researcher from University of Gothenburg. The author has contributed to research in topics: Traumatic brain injury & Concussion. The author has an hindex of 19, co-authored 42 publications receiving 1418 citations. Previous affiliations of Pashtun Shahim include Sahlgrenska University Hospital & Luleå University of Technology.
Papers
More filters
Journal ArticleDOI
Blood Biomarkers for Brain Injury in Concussed Professional Ice Hockey Players
Pashtun Shahim,Yelverton Tegner,David H. Wilson,Jeffrey Randall,Tobias Skillbäck,David Pazooki,Birgitta Kallberg,Kaj Blennow,Henrik Zetterberg,Henrik Zetterberg +9 more
TL;DR: In this article, a lack of objective biomarkers for brain damage hampers acute diagnosis and clinical decision-making about return to play after sports-related concussive injury.
Journal ArticleDOI
Serum neurofilament light protein predicts clinical outcome in traumatic brain injury
Pashtun Shahim,Magnus Gren,Victor Liman,Ulf Andreasson,Niklas Norgren,Yelverton Tegner,Niklas Mattsson,Niels Andreasen,M. Öst,Henrik Zetterberg,Henrik Zetterberg,Bengt Nellgård,Kaj Blennow +12 more
TL;DR: Data suggests that measurement of serum NF-L may be useful to assess the severity of neuronal injury following sTBI, and compares the diagnostic and prognostic utility ofNF-L with the established blood biomarker S100B.
Journal ArticleDOI
Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports
TL;DR: Serum NFL increased over time in hockey players, and the levels returned to normal at return to play, indicating that serum NFL could separate players with rapidly resolving postconcussion symptoms (PCS) from those with prolonged PCS.
Journal ArticleDOI
Neurofilament light and tau as blood biomarkers for sports-related concussion
TL;DR: Serum NfL outperformed tau, S100B, and NSE as a biomarker for SRC and may be useful to identify individuals at risk of prolonged PCS, and may aid in biomarker-informed decisions with regard to when RTP should be considered.
Journal ArticleDOI
Time course and diagnostic utility of NfL, tau, GFAp, and UCH-L1 in subacute and chronic TBI
Pashtun Shahim,Adam Politis,Andre van der Merwe,Brian Moore,Vindhya Ekanayake,Sara M. Lippa,Sara M. Lippa,Yi-Yu Chou,Dzung L. Pham,John A. Butman,Ramon Diaz-Arrastia,Henrik Zetterberg,Kaj Blennow,Kaj Blennow,Jessica M. Gill,David L. Brody,Leighton Chan +16 more
TL;DR: Serum NfL shows greater diagnostic and prognostic utility than GFAP, tau, and UCH-L1 for subacute and chronic TBI, and is associated with the likely rate of MRI brain atrophy and DTI measures of progression of TAI.